150 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
22 Recruiting Treatment of Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Procedure: Lymphadenectomy
23 Unknown  Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Cervical Cancer;   Endometrial Cancer;   Esophageal Cancer;   Fallopian Tube Cancer;   Gastric Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: informational intervention;   Procedure: assessment of therapy complications;   Procedure: psychosocial assessment and care
24 Recruiting Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Conditions: Advanced Solid Malignancy;   Safety and Tolerability;   Pharmacokinetics;   Pharmacodynamics;   Tumour Response;   Advanced or Metastatic Breast Cancer;   Ovarian Cancer;   Cervical Cancer;   Endometrial Cancer;   PIK3CA;   AKT1;   ER+;   HER2+
Intervention: Drug: AZD5363
25 Recruiting Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery
Condition: Early Stage Endometrial Cancer
Interventions: Procedure: Upper vaginectomy;   Radiation: Post-operative brachytherapy;   Procedure: Standard procedures
26 Not yet recruiting Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Recurrent Ovarian Cancer;   Recurrent Endometrial Cancer
Interventions: Drug: BKM120;   Drug: Nabpaclitaxel
27 Unknown  Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
Conditions: Endometrial Hyperplasia;   Endometrial Cancer
Interventions: Drug: progesterone;   Drug: activella
28 Unknown  Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: lymphadenectomy;   Procedure: therapeutic conventional therapy;   Procedure: Positron Emission Tomography/ Computed Tomography;   Radiation: fludeoxyglucose F 18
29 Recruiting High Risk Endometrial Cancer and Lymph Nodes Metastasis
Condition: Gynecologic Cancer
Interventions: Procedure: PET/CT Scan;   Procedure: Sentinel Lymph Node Mapping
30 Unknown  A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Drug: paclitaxel
31 Recruiting Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Condition: Endometrial Cancer
Interventions: Device: ISB dye and standard white light imaging;   Device: ICG dye and FireFly fluorescence imaging
32 Recruiting Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics
Conditions: Endometrial Cancer;   Treatment by Robotic Assisted Laparoscopy Hysterectomy
Intervention:
33 Recruiting Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease
Conditions: Breast Cancer;   Cervical Cancer;   Endometrial Cancer;   Ovarian Cancer;   Primary Peritoneal Carcinoma;   Bone Sarcoma;   Cancer;   Solid Tumor
Intervention: Drug: compound 31543 Calcitriol
34 Recruiting Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
Conditions: Endometrial Cancer;   Cervical Cancer
Intervention: Drug: IC Green
35 Recruiting Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: single-port laparoscopic surgical staging;   Procedure: Four-port laparoscopic surgical staging
36 Recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
Conditions: Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
37 Recruiting RAD/Letrozole/Metformin
Condition: Endometrial Cancer
Interventions: Drug: Metformin;   Drug: Letrozole;   Drug: Everolimus
38 Recruiting HuMax®-TF-ADC Safety Study in Patients With Solid Tumors
Conditions: Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer (CRPC);   Esophagus Cancer;   Lung Cancer(NSCLC)
Intervention: Drug: HuMax-TF-ADC
39 Not yet recruiting Virexxa (Sodium Cridanimod) in Conjunction With Progestin Therapy in Patients With Progesterone Receptor Negative Recurrent or Persistent Endometrial Carcinoma
Condition: Recurrent or Persistent Endometrial Carcinoma
Intervention: Drug: Sodium cridanimod
40 Unknown  ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers
Conditions: Ovarian Cancer;   Endometrium Cancer
Intervention: Other: SCP care

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years